Market Cap
kr.59.2b
Last Updated
2021/01/25 18:05 UTC
Data Sources
Company Financials +
Executive Summary
Ambu A/S develops, manufactures, and sells medical devices to hospitals, clinics, and rescue services worldwide. More Details
Rewards
Risk Analysis
Snowflake Analysis
High growth potential with adequate balance sheet.
Similar Companies
Share Price & News
How has Ambu's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: AMBU B is not significantly more volatile than the rest of Danish stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: AMBU B's weekly volatility (6%) has been stable over the past year.
Market Performance
7 Day Return
-2.6%
AMBU B
4.1%
DK Medical Equipment
1.3%
DK Market
1 Year Return
114.6%
AMBU B
23.0%
DK Medical Equipment
26.9%
DK Market
Return vs Industry: AMBU B exceeded the Danish Medical Equipment industry which returned 19% over the past year.
Return vs Market: AMBU B exceeded the Danish Market which returned 23.7% over the past year.
Shareholder returns
| AMBU B | Industry | Market | |
|---|---|---|---|
| 7 Day | -2.6% | 4.1% | 1.3% |
| 30 Day | -1.9% | 1.5% | 3.2% |
| 90 Day | 25.5% | 4.8% | 13.1% |
| 1 Year | 114.9%114.6% | 24.4%23.0% | 29.3%26.9% |
| 3 Year | 91.1%89.7% | 81.8%75.3% | 56.1%43.9% |
| 5 Year | 484.9%475.2% | 135.9%116.9% | 68.0%46.4% |
Long-Term Price Volatility Vs. Market
How volatile is Ambu's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
A Look At The Fair Value Of Ambu A/S (CPH:AMBU B)1 month ago | Simply Wall St
Here's Why Ambu (CPH:AMBU B) Can Manage Its Debt Responsibly1 month ago | Simply Wall St
What Percentage Of Ambu A/S (CPH:AMBU B) Shares Do Insiders Own?Valuation
Is Ambu undervalued compared to its fair value and its price relative to the market?
8.9%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: AMBU B (DKK248.5) is trading below our estimate of fair value (DKK272.82)
Significantly Below Fair Value: AMBU B is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: AMBU B is poor value based on its PE Ratio (254.2x) compared to the DK Medical Equipment industry average (70.7x).
PE vs Market: AMBU B is poor value based on its PE Ratio (254.2x) compared to the Danish market (17.5x).
Price to Earnings Growth Ratio
PEG Ratio: AMBU B is poor value based on its PEG Ratio (7.7x)
Price to Book Ratio
PB vs Industry: AMBU B is overvalued based on its PB Ratio (26x) compared to the DK Medical Equipment industry average (10.3x).
Next Steps
Future Growth
How is Ambu forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
33.1%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AMBU B's forecast earnings growth (33.1% per year) is above the savings rate (0.2%).
Earnings vs Market: AMBU B's earnings (33.1% per year) are forecast to grow faster than the Danish market (12.5% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: AMBU B's revenue (17.5% per year) is forecast to grow faster than the Danish market (6.6% per year).
High Growth Revenue: AMBU B's revenue (17.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AMBU B's Return on Equity is forecast to be high in 3 years time (25.5%)
Next Steps
Past Performance
How has Ambu performed over the past 5 years?
8.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AMBU B has high quality earnings.
Growing Profit Margin: AMBU B's current net profit margins (6.8%) are lower than last year (11.2%).
Past Earnings Growth Analysis
Earnings Trend: AMBU B's earnings have grown by 8% per year over the past 5 years.
Accelerating Growth: AMBU B's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AMBU B had negative earnings growth (-23.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (-23.9%).
Return on Equity
High ROE: AMBU B's Return on Equity (10.2%) is considered low.
Next Steps
Financial Health
How is Ambu's financial position?
Financial Position Analysis
Short Term Liabilities: AMBU B's short term assets (DKK1.2B) exceed its short term liabilities (DKK1.0B).
Long Term Liabilities: AMBU B's short term assets (DKK1.2B) do not cover its long term liabilities (DKK1.5B).
Debt to Equity History and Analysis
Debt Level: AMBU B's debt to equity ratio (53%) is considered high.
Reducing Debt: AMBU B's debt to equity ratio has reduced from 76.1% to 53% over the past 5 years.
Debt Coverage: AMBU B's debt is well covered by operating cash flow (23.5%).
Interest Coverage: AMBU B's interest payments on its debt are well covered by EBIT (15.3x coverage).
Balance Sheet
Next Steps
Dividend
What is Ambu current dividend yield, its reliability and sustainability?
0.12%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: AMBU B's dividend (0.12%) isn’t notable compared to the bottom 25% of dividend payers in the Danish market (0.95%).
High Dividend: AMBU B's dividend (0.12%) is low compared to the top 25% of dividend payers in the Danish market (3.39%).
Stability and Growth of Payments
Stable Dividend: AMBU B is not paying a notable dividend for the Danish market, therefore no need to check if payments are stable.
Growing Dividend: AMBU B is not paying a notable dividend for the Danish market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: AMBU B is not paying a notable dividend for the Danish market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AMBU B's dividend in 3 years as they are not forecast to pay a notable one for the Danish market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
6.9yrs
Average management tenure
CEO
Juan Gonzalez (48 yo)
1.67yrs
Tenure
kr.24,000,000
Compensation
Mr. Juan Jose Gonzalez has been Chief Executive Officer of Ambu A/S since May 15, 2019 and also had been its President since 2019 until 2019. He serves as Member of Executive Board at Ambu A/S. He is Direc...
CEO Compensation Analysis
Compensation vs Market: Juan's total compensation ($USD3.91M) is about average for companies of similar size in the Danish market ($USD3.57M).
Compensation vs Earnings: Juan's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Member of Executive Board | 1.67yrs | kr.24.00m | 0.065% DKK 38.8m | |
| CFO, Executive VP of Global Finance | 8yrs | kr.7.90m | 0.0075% DKK 4.4m | |
| Head of HR Systems & Employee Representative Director | 4yrs | kr.300.00k | 0.0040% DKK 2.4m | |
| Senior Director of Anaesthesia | 8yrs | kr.300.00k | 0.0028% DKK 1.7m | |
| Head of IP & Employee Representative Director | 4yrs | kr.300.00k | 0.0012% DKK 693.0k | |
| Executive Vice President of Global Operations | 2.25yrs | no data | no data | |
| IR Manager | no data | no data | no data | |
| Managing Director | no data | no data | no data | |
| Executive Vice President of Global Innovation & Chief Innovation Officer | 6yrs | no data | no data | |
| CEO & President of USA | 7.75yrs | no data | no data | |
| Director General of Ambu S.R.L. & Ambu S.L. | no data | no data | no data | |
| Managing Director of Ambu UK | 19.83yrs | no data | no data |
6.9yrs
Average Tenure
48yo
Average Age
Experienced Management: AMBU B's management team is seasoned and experienced (6.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Head of HR Systems & Employee Representative Director | 4yrs | kr.300.00k | 0.0040% DKK 2.4m | |
| Senior Director of Anaesthesia | 8yrs | kr.300.00k | 0.0028% DKK 1.7m | |
| Head of IP & Employee Representative Director | 4yrs | kr.300.00k | 0.0012% DKK 693.0k | |
| Independent Vice-Chairman of the Board | 1yr | kr.450.00k | 0.10% DKK 60.9m | |
| Independent Vice Chairman | no data | kr.700.00k | 0.027% DKK 16.0m | |
| Independent Director | 5.08yrs | kr.400.00k | 0.0043% DKK 2.5m | |
| Director | 1.08yrs | kr.315.00k | 0.0016% DKK 953.6k | |
| Chairman of the Board | 1yr | no data | no data |
4.0yrs
Average Tenure
49yo
Average Age
Experienced Board: AMBU B's board of directors are considered experienced (4 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Ambu A/S's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Ambu A/S
- Ticker: AMBU B
- Exchange: CPSE
- Founded: 1937
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: kr.59.232b
- Shares outstanding: 247.94m
- Website: https://www.ambu.com
Number of Employees
Location
- Ambu A/S
- Baltorpbakken 13
- Ballerup
- Capital Region of Denmark
- 2750
- Denmark
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| AMBU B | CPSE (OMX Nordic Exchange Copenhagen) | Yes | Class B Shares | DK | DKK | Aug 1992 |
| AMBF.F | OTCPK (Pink Sheets LLC) | Yes | Class B Shares | US | USD | Aug 1992 |
| AMBUBC | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Class B Shares | GB | DKK | Aug 1992 |
| 0MJF | LSE (London Stock Exchange) | Yes | Class B Shares | GB | DKK | Aug 1992 |
| AMBU N | BMV (Bolsa Mexicana de Valores) | Yes | Class B Shares | MX | MXN | Aug 1992 |
| AMBB.Y | OTCPK (Pink Sheets LLC) | UNSPONSORD ADR | US | USD | Jul 2017 |
Biography
Ambu A/S develops, manufactures, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient mon...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/25 18:05 |
| End of Day Share Price | 2021/01/25 00:00 |
| Earnings | 2020/09/30 |
| Annual Earnings | 2020/09/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.